Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium

Stem Cells

Volumn 15, Issue 1, 1997, Pages 18-32

  Birkmann, Josef ^a,b   Oez, Sadik ^a   Smetak, Manfred ^a   Kaiser, Gerwin ^a   Kappauf, Herbert ^a   Gallmeier, Walter M ^a  

^a City Hospital Nürnberg   (Germany)

^b Medizinische Klinik 5   (Germany)

Author keywords

Human; Lineage specificity; Maturation; Megakaryocytes; Progenitor cells; Serum free culture; Thrombopoietin

Indexed keywords

CD34 ANTIGEN; CYTOKINE; ERYTHROPOIETIN; GLYCOPHORIN A; INTERLEUKIN 3; RECOMBINANT THROMBOPOIETIN;

ARTICLE; CELL PROLIFERATION; CELL SUBPOPULATION; CELL SURVIVAL; DRUG EFFECT; ERYTHROID CELL; HUMAN; HUMAN CELL; IMMOBILIZED CELL; LEUKAPHERESIS; MEGAKARYOCYTE; STEM CELL; TARGET CELL;

EID: 0031017147     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.150018     Document Type: Article

References (50)

1. Vigon I, Mornon J-P, Cocault L et al. Molecular cloning and characterization of MPL, the human homolog of the v-mpl oncogene: identification of a member of the hematopoietic growth factor receptor superfamily. Proc Natl Acad Sei USA 1992;89:5640-5644.
2. Debili N, Wendling F, Cosman D et al. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets. Blood 1995;85(suppl 2):391-401.
3. Methia N, Louache F, Vainchenker W et al. Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryopoiesis. Blood 1993;82:1395-1401.
4. de Sauvage FJ, Hass PE, Spencer SD et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-538.
5. Bartley TD, Bogenberger J, Hunt P. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117-1124.
6. Lok S, Kaushansky K, Holly RD et al. Cloning and expression of murine thrombopoetin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-568.
7. Kaushansky K, Lok S, Holly RD et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoetin. Nature 1994;369:568-571.
8. Kato T, Iwamatsu A, Shimada Y et al. Purification and characterization of thrombopoietin derived from thrombocytopenic rat plasma. Blood 1994;84(suppl):329a.
9. Kato T, Ogami K, Shimada Y et al. Purification and characterization of thrombopoetin. J Biochem 1995;118:229-236.
10. Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 1994;91:11104-11108.
11. Gurney AL, Kuang WJ, Xie MH et al. Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. Blood 1995;85:981-988.
12. Sohma Y, Akahori H, Seki N et al. Molecular cloning and chromosomal localization of the human thrombopoetin gene. FEBS Lett 1994;353:57-61.
13. Lok S, Foster DC. The structure, biology and potential therapeutic applications of recombinant thrombopoetin. STEM CELLS 1994;12:586-598.
14. Hunt P. The physiologic role and therapeutic potential of the Mpl-ligand in thrombopoiesis. STEM CELLS 1995;13:579-587.
15. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-431.
16. Ulich TR, del Castillo J, Yin S et al. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 1995;86:971-976.
17. Hokom MM, Lacey D, Kinstler OB et al. Pegylated megakaryocyte growth and development factor abrogates the lethal thrombocytopenia associated with carboplatin and irradiation in mice. Blood 1995;86:4486-4492.
18. Farese AM, Hunt P, Boone T et al. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood 1995;86:54-59.
19. Debili N, Hegyi E, Navarro S. In vitro effects of hematopoietic growth factors on the proliferation, endoreplication, and maturation of human megakaryocytes. Blood 1991;77:23-26.
20. Choi ES, Hokom MM, Bartley TD et al. Megakaryocyte growth and development factor produces functional human platelets in vitro. STEM CELLS 1995;13:317-322.
21. Chen JC, HercegHarjacek L, Groopman JE et al. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin. Blood 1995;86:4054-4062.
22. Lebkowski JS, Schain LR, Okarma TB. Serum-free culture of hematopoietic stem cells: a review. STEM CELLS 1995;13:607-612.
23. Eliason JF, Odartchenko N. Colony formation by primitive hemopoietic progenitor cells in serum-free medium. Proc Natl Acad Sci USA 1985;82:775-779.
24. Iizuka Y, Murphy MJ Jr. Colony formation of granulocyte (CFU-G) and macrophage (CFU-M) precursors in serum-and albumin-free culture: effect of transferrin on clonal growth. Exp Cell Biol 1986;54:275-280.
25. Drouet X, Douay L, Giarratana MC et al. Human liquid bone marrow culture in serum-free medium. Br J Haematol 1989;73:143-147.
26. + cells. Blood Cells 1994;20:404-410.
27. Kobayashi M, Laver JH, Kato T et al. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 1995;86:2494-2499.
28. Broudy VC, Lin NL, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood 1995;85:1719-1726.
29. Bruno E, Cooper RJ, Briddell RA et al. Further examination of the effects of recombinant cytokines on the proliferation of human megakaryocyte progenitor cells. Blood 1991;77:2339-2346.
30. Ganser A, Lindemann A, Seipelt G et al. Effect of recombinant human interleukin 3 in patients with normal hematopoiesis and in patients with bone marrow failure. Blood 1990;76:666-676.
31. Hunt P, Li YS, Nichol JL et al. Purification and biologic characterization of plasma-derived megakaryocyte growth and development factor. Blood 1995;86:540-547.
32. Nichol JL, Hornkohl AC, Choi ES et al. Enrichment and characterization of peripheral blood-derived megakaryocyte progenitors that mature in short-term liquid culture. STEM CELLS 1994;12:494-505.
33. Krause DS, Fackler MJ, Civin CI et al. CD34: structure, biology, and clinical utility. Blood 1996;87:1-13.
34. Block KL, Poncz M. Platelet glycoprotein IIb gene expression as a model of megakaryocyte-specific expression. STEM CELLS 1995;13:135-145.
35. Shaw S, Luce GG, Gilks WR et al. Leukocyte differentiation antigen database in leukocyte typing V. Oxford: Oxford University Press, 1994.
36. Choi ES, Nichol JL, Hokom MM et al. Platelets generated in vitro from proplatelet-displaying human megakaryocytes are functional. Blood 1995;85(suppl 2):402-413.
37. +) cells measured under conditions that prevent P-selectin-mediated binding of platelets. Blood 1995;86:3771-3782.
38. Lerner NB, Nocka KH, Cole SR et al. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 1991;77:1876-1883.
39. +) cells in the absence of other growth factors. Exp Hematol 1995;23:413-421.
40. Keller JR, Ortiz M, Ruscetti FW. Steel factor (c-kit ligand) promotes the survival of hematopoietic stem progenitor cells in the absence of cell division. Blood 1995;86:1757-1764.
41. Guerriero R, Testa U, Gabbianelli M et al. Unilineage megakaryocytic proliferation and differentiation of purified hematopoietic progenitors in serum-free liquid culture. Blood 1995;86:3725-3736.
42. Debili N, Wendung F, Katz A et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995;86:2516-2525.
43. DeJong MO, Wagemaker G, Wognum AW. Separation of myeloid and erythroid progenitors based on expression of CD34 and c-kit. Blood 1995;86:4076-4085.
44. Uoshima N, Ozawa M, Kimura S et al. Changes in c-Kit expression and effects of SCF during differentiation of human erythroid progenitor cells. Br J Haematol 1995;91:30-36.
45. Muta K, Krantz SB, Bondurant MC et al. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood 1995;86:572-580.
46. Banu N, Wang JF, Deng BJ et al. Modulation of megakaryocytopoiesis by thrombopoietin: the c-Mpl ligand. Blood 1995;86:1331-1338.
47. Kaushansky K, Broudy VC, Grossmann A et al. Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy. J Clin Invest 1995;96:1683-1687.
48. Kaushansky K, Lin N, Grossmann A et al. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice. Exp Hematol 1996;24:265-269.
49. Alexander WS, Roberts AW, Nicola NA et al. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietin receptor c-Mpl. Blood 1996;87:2162-2170.
50. Ku H, Yonemura Y, Kaushansky K et al. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other eary acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 1996;87:4544-4551.